Climb Bio, Inc. (CLYM) vs Helus Pharma Inc. (HELP)
A side-by-side comparison of Climb Bio, Inc. and Helus Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLYM
Climb Bio, Inc.
$10.68HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
HELP
Helus Pharma Inc.
$10.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CLYM vs HELP
growth of $100 · dividends reinvested · last 1yCLYM +510.5% (+510.5%/yr)HELP +93.2% (+93.2%/yr)CLYM compounded faster over this window
CLYM HELP
CLYM vs HELP: by the numbers
- •HELP is the larger company ($667M vs $612M market cap).
- •HELP is profitable (329.09% net margin) while CLYM runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CLYM | HELP |
|---|---|---|
| P/B ratio | 2.55 | 2.76 |
Profitability
| Metric | CLYM | HELP |
|---|---|---|
| Gross margin | 0.00% | 100.27% |
| Operating margin | 0.00% | 317.06% |
| Net margin | 0.00% | 329.09% |
| ROE | -24.06% | -75.79% |
| ROIC | -26.94% | -73.27% |
Frequently asked
- Is CLYM or HELP more profitable?
- HELP runs the higher net margin — CLYM at 0.00% versus HELP at 329.09%.
Go deeper
Dig into the metrics
Climb Bio ROEHelus Pharma ROEClimb Bio operating marginHelus Pharma operating marginClimb Bio revenue growthHelus Pharma revenue growthClimb Bio free cash flowHelus Pharma free cash flow
Climb Bio & Helus Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.